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Background
Adenoviral (Ad) vectors have been used for a variety of
vaccine applications. Traditionally, Ad-based vaccines
are designed to express antigens through transgene
expression. However, in some cases these conventional
Ad-based vaccines have had sub-optimal clinical results.
These sub-optimal results are attributed in part to pre-
existing Ad serotype 5(Ad5) immunity. To circumvent
the need for transgene antigen expression, the “antigen
capsid-incorporation” strategy has been developed and
used for Ad-based vaccine development. In addition, to
increase the magnitude and/or breadth of antigen-speci-
fic antibody response, this strategy can be utilized. The
major capsid protein hexon has been utilized for antigen
display due to hexon’s natural role in the generation of
anti-Ad immune response and its numerical representa-
tion within the Ad virion.
Methods
Based on our abilities to manipulate Ad5 HVR2 and
HVR5, we sought to manipulate Ad5 HVR1 in the con-
text of HIV antigen display. More importantly, peptide
incorporation within HVR1 was utilized in combination
with other HVRs. In order to create a multivalent vac-
cine vector, we created vectors that display antigens
within HVR1 and HVR2 or HVR1 and HVR5. To date
this is the first report where dual antigens are displayed
within one Ad hexon particle. These vectors utilize
HVR1 as an incorporation site for a seven amino acid
region of the HIV glycoprotein 41; in combination with
a six Histidine (His6) incorporation within HVR2 or
HVR5.
Results
Our study, illustrates that these multivalent antigen vec-
tors are viable, present HIV antigen as well as His6
within one Ad virion particle. Furthermore, mouse
immunization with these vectors; demonstrate that these
vectors can elicit a HIV and His6 epitope-specific
humoral immune response.
Conclusion
Our study focuses on generation of proof of concept
vectors that can ultimately result in the development of
multivalent vaccine vectors displaying dual antigens
within the hexon of one Ad virion particle.
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